Amdocs (NASDAQ:DOX) Hits New 1-Year High at $69.95

Amdocs Limited (NASDAQ:DOX)’s share price hit a new 52-week high during mid-day trading on Friday . The company traded as high as $69.95 and last traded at $69.74, with a volume of 4789 shares. The stock had previously closed at $69.27.

DOX has been the subject of several analyst reports. BidaskClub upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a report on Thursday. JPMorgan Chase & Co. reduced their price objective on shares of Amdocs from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, November 13th. Finally, Stifel Nicolaus raised their price objective on shares of Amdocs from $70.00 to $75.00 and gave the company a “buy” rating in a report on Friday, November 15th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.33.

The company has a market capitalization of $9.74 billion, a price-to-earnings ratio of 17.15, a PEG ratio of 1.92 and a beta of 0.40. The stock has a 50 day simple moving average of $67.35 and a two-hundred day simple moving average of $64.49.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, November 12th. The technology company reported $1.08 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.08. Amdocs had a return on equity of 15.98% and a net margin of 11.73%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the firm posted $0.99 EPS. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. On average, equities research analysts anticipate that Amdocs Limited will post 4.25 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 24th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.285 per share. This represents a $1.14 annualized dividend and a yield of 1.63%. The ex-dividend date is Monday, December 30th. Amdocs’s payout ratio is 28.01%.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Arizona State Retirement System raised its holdings in Amdocs by 6.3% during the second quarter. Arizona State Retirement System now owns 59,411 shares of the technology company’s stock worth $3,689,000 after purchasing an additional 3,523 shares in the last quarter. Strs Ohio purchased a new position in shares of Amdocs in the 2nd quarter valued at $549,000. Steward Partners Investment Advisory LLC purchased a new position in shares of Amdocs in the 2nd quarter valued at $60,000. SG Americas Securities LLC raised its stake in Amdocs by 13.8% during the 2nd quarter. SG Americas Securities LLC now owns 23,034 shares of the technology company’s stock worth $1,430,000 after acquiring an additional 2,788 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its stake in Amdocs by 1.3% during the 2nd quarter. Janney Montgomery Scott LLC now owns 48,942 shares of the technology company’s stock worth $3,039,000 after acquiring an additional 648 shares in the last quarter. 89.23% of the stock is owned by hedge funds and other institutional investors.

Amdocs Company Profile (NASDAQ:DOX)

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Recommended Story: Balanced Fund

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.